The impact of Covid-19 on gamete shipping by Australian and New Zealand patients.

Aust N Z J Obstet Gynaecol

School of Social Sciences, Faculty of Arts, Monash University, Melbourne, Victoria, 3800, Australia.

Published: February 2023

AI Article Synopsis

  • Cross-border surrogacy and egg donation in Australia has seen a rise, but data on usage patterns has been challenging to gather due to a lack of documentation on international reproductive care.
  • The Covid-19 travel ban forced many Australians seeking reproductive services to rely heavily on local IVF clinics, which led to increased shipping of gametes.
  • Data from 31 clinics revealed a significant rise in both domestic (78% of shipments) and international (22%) gamete exports, with the US being the most common destination for international shipments (39%).

Article Abstract

Background: Cross-border surrogacy and egg donor arrangements are an increasingly common means to family building. Establishing patterns of use has always been difficult in relation to Australian patients. Accurate data is stymied by lack of documentation of international third-party reproductive care available to Australian authorities. When international travel bans came into effect, it is hypothesised that those planning to use cross-border reproductive care had to rely significantly more on local in vitro fertilisation (IVF) clinics for services such as sperm freezing, embryo creation and gamete release procedures.

Aim: To quantify and characterise the impact of the Covid-19-related travel ban on international and interstate gamete shipping by Australian IVF clinics.

Materials And Methods: Thirty-one Australian and New Zealand IVF clinics were invited to provide de-identified data on interstate and international gamete export applications from two 12 month time periods pre- and during Covid-19-related international travel lockdowns. Seven IVF organisations provided data on: patient age; type of gametes exported; destination country/state; and date gamete release approved.

Results: Most gametes (78%) were shipped to another Australian IVF clinic and 22% internationally. Patient-initiated shipping domestically and internationally both showed significant increases when comparing pre- and post-Covid datasets. Of the 21 destination countries reported for international shipments, the US was the commonest (39%), followed by Ukraine (21%) and Canada (9%).

Conclusions: The inability of involuntarily infertile patients to travel internationally, rather than halt cross-border reproductive care, has led to a significant increase in the uptake of gamete shipping. The high proportion of internationally shipped gametes going to the US and Ukraine is likely a reflection of the availability of surrogates and donors and more amenable legal frameworks.

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajo.13623DOI Listing

Publication Analysis

Top Keywords

gamete shipping
12
reproductive care
12
shipping australian
8
australian zealand
8
international travel
8
cross-border reproductive
8
ivf clinics
8
gamete release
8
australian ivf
8
gamete
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!